Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Morgan H. Romine"'
Autor:
Jennifer C. Kasemeier-Kulesa, Morgan H. Romine, Jason A. Morrison, Caleb M. Bailey, Danny R. Welch, Paul M. Kulesa
Publikováno v:
Biology Open, Vol 7, Iss 1 (2018)
Melanoma pathogenesis from normal neural crest-derived melanocytes is often fatal due to aggressive cell invasion throughout the body. The identification of signals that reprogram de-differentiated, metastatic melanoma cells to a less aggressive and
Externí odkaz:
https://doaj.org/article/e0939d5a61be422197aa0ffe3af04e1e
Autor:
Susan McCune, Lynn D. Hudson, Elektra J. Papadopoulos, Sarah Sheehan, Gerri Baer, Michelle Campbell, Robert Lim, Gregory W. Daniel, Morgan H. Romine
Publikováno v:
Ther Innov Regul Sci
Chronic pulmonary and respiratory conditions associated with preterm birth are incompletely characterized, complicating long-term treatment and development of more effective therapies. Stakeholders face challenges in the development of validated, cli
Publikováno v:
Clinical Pharmacology & Therapeutics. 105:809-811
Autor:
Matthew Rosenberg, Morgan H. Romine, Esther H. Zhou, Sarah Sheehan, Jessica Burnell, Ellen Pinnow, Gerald J. Dal Pan
Publikováno v:
Pharmacoepidemiology and drug safetyREFERENCES. 29(9)
Purpose Prior literature reviews have identified gaps in understanding of how postmarketing safety labeling changes and related FDA communications impact key clinical and behavioral outcomes. We conducted a review of newly published studies on this t
Autor:
Alexis Caze, Morgan H. Romine, Céline Audibert, Gregory W. Daniel, Jonathan Leff, Mark McClellan
Publikováno v:
Drug Development and Industrial Pharmacy. 43:74-78
Policy and legislative efforts to improve the biomedical innovation process must rely on a detailed and thorough analysis of drug development and industry output.As part of our efforts to build a publicly-available database on the characteristics of
Autor:
Morgan H. Romine, Issam Zineh, Darrell R. Abernethy, Cornelis E. C. A. Hop, Gregory W. Daniel, Akintunde Bello, Mark McClellan
Publikováno v:
Clinical Pharmacology & Therapeutics. 101:22-24
Current trends in pronounced late-stage attrition rates of promising drug candidates are a pressing concern for patients, providers, and other stakeholders across the health care system. Here, we describe six areas in which clinical pharmacology meth
Autor:
Céline Audibert, Gregory W. Daniel, Alexis Caze, Mark McClellan, Morgan H. Romine, Jonathan Leff
Publikováno v:
Health Affairs. 34:319-327
New drugs and biologics have had a tremendous impact on the treatment of many diseases. However, available measures suggest that pharmaceutical innovation has remained relatively flat, despite substantial growth in research and development spending.
Autor:
Morgan H. Romine, Jennifer C. Kasemeier-Kulesa, Jason A. Morrison, Paul M. Kulesa, Caleb M. Bailey, Danny R. Welch
Publikováno v:
Biology Open, Vol 7, Iss 1 (2018)
Biology Open
Biology Open
Melanoma pathogenesis from normal neural crest-derived melanocytes is often fatal due to aggressive cell invasion throughout the body. The identification of signals that reprogram de-differentiated, metastatic melanoma cells to a less aggressive and
Autor:
Jennifer C. Kasemeier-Kulesa, Jessica M. Teddy, Paul M. Kulesa, Morgan H. Romine, Rebecca McLennan
Publikováno v:
Developmental Biology. 339:114-125
The neural crest is an excellent model to study embryonic cell migration, since cell behaviors can be studied in vivo with advanced optical imaging and molecular intervention. What is unclear is how molecular signals direct neural crest cell (NCC) mi
Autor:
Jennifer C. Kasemeier-Kulesa, Morgan H. Romine, Rebecca McLennan, Frances Lefcort, Paul M. Kulesa
Publikováno v:
The FASEB Journal. 25